about
Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodiesScreening of an endothelial cDNA library identifies the C-terminal region of Nedd5 as a novel autoantigen in systemic lupus erythematosus with psychiatric manifestations.Linking susceptibility genes and pathogenesis mechanisms using mouse models of systemic lupus erythematosusThe MRL/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosus.Seizures in patients with systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA LIV).Elevated immunoglobulin levels in the cerebrospinal fluid from lupus-prone mice.Anti-endothelial antibodies and neuropsychiatric systemic lupus erythematosus.Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.Chinese SLE treatment and research group registry: III. association of autoantibodies with clinical manifestations in Chinese patients with systemic lupus erythematosus.A Case of Mania in a Patient with Systemic Lupus Erythematosus: Can Its Inflammatory Pathogenesis be Applied to Primary Mood Disorders?Ribosomal P autoantibodies are present before SLE onset and are directed against non-C-terminal peptidesNeurocognitive dysfunction in systemic lupus erythematosus: association with antiphospholipid antibodies, disease activity and chronic damage.NGcGM3 ganglioside: a privileged target for cancer vaccinesPsychosis in a young female - a diagnostic and therapeutic challenge.16/6-idiotype expressing antibodies induce brain inflammation and cognitive impairment in mice: the mosaic of central nervous system involvement in lupus.Association between microscopic brain damage as indicated by magnetization transfer imaging and anticardiolipin antibodies in neuropsychiatric lupus.Increased serum levels of anti-ganglioside M1 auto-antibodies in autistic children: relation to the disease severity.Behavioral heterogeneity in an animal model of neuropsychiatric lupus.The possible link between elevated serum levels of epithelial cell-derived neutrophil-activating peptide-78 (ENA-78/CXCL5) and autoimmunity in autistic children.Autoantibodies Affect Brain Density Reduction in Nonneuropsychiatric Systemic Lupus Erythematosus Patients.Cell-ELISA detection of antineuronal antibodies in central nervous system involvement in systemic lupus erythematosus.A lack of association between elevated serum levels of S100B protein and autoimmunity in autistic children.Neuroimmunopathology in a murine model of neuropsychiatric lupusAntiphospholipid syndrome presenting as progressive neuropsychiatric disorders: two case reportsNeuropsychiatric involvement in pediatric systemic lupus erythematosus.Two case reports indicating the dilemma in diagnosing lupus cerebritis.The P domain of the P0 protein of Plasmodium falciparum protects against challenge with malaria parasitesSmell and autoimmunity: a comprehensive review.Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus: a systematic review.Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers.Ribosomal P antibody: 30 years on the road.A critical analysis of the tools to evaluate neuropsychiatric lupus.Effects of sustained i.c.v. infusion of lupus CSF and autoantibodies on behavioral phenotype and neuronal calcium signalingInternational multicenter evaluation of autoantibodies to ribosomal P proteins.Neuropsychiatric Symptoms as The First Manifestation of Juvenile Systemic Lupus Erythematosus: A Complicated Case with Klinefelter's Syndrome.Characterization of the human autoimmune response to the major C-terminal epitope of the ribosomal P proteins.Markers of acute neuropsychiatric systemic lupus erythematosus: a multidisciplinary evaluation.The positive association between elevated blood lead levels and brain-specific autoantibodies in autistic children from low lead-polluted areas.Clinical Factors Associated with Brain Volume Reduction in Systemic Lupus Erythematosus Patients without Major Neuropsychiatric Manifestations.Antibodies to microtubule-associated protein-2 in the cerebrospinal fluid are a useful diagnostic biomarker for neuropsychiatric systemic lupus erythematosus.
P2860
Q24805595-CE8352E2-8638-4BC6-B0AF-A632DDEB8E37Q24817163-0EEE7040-F013-479F-9D29-D3C340BF02B5Q26822662-B599A649-0263-47B4-9BD1-34F891592976Q30476952-22DF1FAA-C7F6-4FA4-B255-DA35EC234950Q31129756-33534E3C-0087-4CC9-ADD1-72C1498B8E28Q33217667-DEEFDFD7-3890-473D-822C-9301B5D6C5FDQ33251075-741A06BC-61C3-45E6-B0D9-94D1A73312C6Q33374004-5D610E76-5A20-4D64-936C-5BBDCEE62A77Q33597476-88BC3650-753E-4ACF-9690-DBE4BE4B2C4EQ33881567-3760175E-083B-4D5D-9EC1-761A3CCEA0B7Q33882185-77F24BA4-6920-4DE2-8C77-F9B305B54495Q34213820-D14EB2E3-CAE3-488C-87CA-398C92DD5536Q34247856-C2CB717F-CBE3-42D3-84EE-16711A701751Q34321259-4FC5AF97-CFA8-41E2-B30C-7CFD9D2C699BQ34654431-0885E9C2-4596-4E32-A8D7-79CA57F76A03Q34896821-17A3DA20-BFF0-4197-9401-BEB103C18BC7Q35016370-39E0F0E4-2A2D-4F4F-B927-4537CF2E52DFQ35129275-4A18ADBD-A755-46A2-AA97-6DACA6E61F14Q35222567-14AD49FE-B9CE-4AF2-BBA4-6B68C0B85A8DQ35673044-6F56E4F0-B169-4BBD-9812-C716DDA47FDAQ35760188-131AEDA5-D558-4FB3-A3E5-A04A10CF6AE6Q35984262-786161EF-BD21-4B24-BE05-49DA9AB617F9Q36707992-64639640-E3E0-48E8-8262-0B68FD30EF95Q36884847-FC34CFF6-42D3-4A0D-9FD6-80439B1D0459Q36915630-CC4B6FDC-E257-448D-8F69-BAA1F7381C0AQ37487457-8F0E4D71-5A6A-4802-9BA5-597033C2AE09Q37521643-3CC39CF9-6E3C-4DB6-8B48-1F6CAB5F2A79Q38066803-3CF95BD3-6ACF-4927-8BBF-3C959955AA83Q38222127-E8C54A93-B74A-44A2-8E56-13D872904101Q38247180-EE7D8D28-2B91-44FE-B0EA-69EC8D706603Q40250609-76780A5D-2F48-4D95-AB16-97CFBC103DE3Q40258144-F05FB91B-1829-450D-8398-B292CD84E716Q41524233-FDA6DDBA-5245-4643-B393-0CBA67C9110EQ41952451-0F9E65D5-E94B-4C81-B46E-FB813EE81E60Q42000151-859FADD2-2274-4189-A9EF-1DF904ADDF72Q42596707-377812CD-68B3-4F84-8889-BC7A2E90C1EEQ44436037-9585411F-BF35-4B75-B3FF-9868F1767FABQ48702045-02AA472E-DC15-4C35-8870-2F31C541E765Q49562027-CCEBD1D2-83AC-46E3-B1CF-E0609B6D7A63Q50755682-468EA336-370E-4A71-89AB-CD5F38F66316
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Autoantibodies in neuropsychiatric lupus.
@ast
Autoantibodies in neuropsychiatric lupus.
@en
Autoantibodies in neuropsychiatric lupus.
@nl
type
label
Autoantibodies in neuropsychiatric lupus.
@ast
Autoantibodies in neuropsychiatric lupus.
@en
Autoantibodies in neuropsychiatric lupus.
@nl
prefLabel
Autoantibodies in neuropsychiatric lupus.
@ast
Autoantibodies in neuropsychiatric lupus.
@en
Autoantibodies in neuropsychiatric lupus.
@nl
P2093
P1433
P1476
Autoantibodies in neuropsychiatric lupus
@en
P2093
Ban-Hock Toh
Deanne L V Greenwood
John W Sentry
Veronika M Gitlits
P356
10.1080/08916930290016547
P577
2002-03-01T00:00:00Z